UK Dialysis Market Analysis Report 2022 to 2030

UK Dialysis Market Analysis

$ 3999

The UK dialysis market size was valued at $3.02 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.5 Bn in 2030. Some of the major factors driving the market are increased funding for the research of novel medications, and an increase in patients with end-stage renal disease (ESRD). The market is segmented by Type, Product and Services, and End User. The major market players in the UK dialysis market are DaVita, Baxter, Medtronic, Fresenius Kabi, Physidia, and others.

ID: IN10GBPH010 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Chandani Patel

Buy Now

UK Dialysis Market Executive Summary

The UK dialysis market size was valued at $3.02 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.5 Bn in 2030. In 2020, total healthcare spending in the United Kingdom was $273.42 Bn per person. In 2020, The total current healthcare expenditure in the United Kingdom was 12.0% of the GDP, up from 9.9% in 2019. Preventive care spending reached $ 16.66 Bn in 2020, up 40.8% in real terms, owing partly to increased government spending during the coronavirus (COVID-19) pandemic. The Pharmaceutical Wholesaling industry's market size, measured by revenue, is $ 68.8 Bn in 2022.

The healthcare services industry is composed of businesses, single proprietorships, and partnerships that provide human healthcare services and sell healthcare services and associated products. This industry provides nursing care, residential substance abuse, mental health facilities, dental treatment, and medical and diagnostic laboratory services, among other healthcare services.

The dialysis market in the UK is a significant sector within the healthcare industry. Dialysis is a medical treatment that is used to remove excess waste and fluid from the body in individuals with kidney failure. There are two main types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is a treatment that uses a machine to filter waste and excess fluids from the blood, while peritoneal dialysis uses the lining of the abdomen to filter waste and excess fluids from the body.

UK Dialysis Market

Market Dynamics

Market Growth Drivers

One of the main reasons propelling market growth in the UK is the expanding older population. The population of England and Wales has continued to age, with Census 2021 results confirming there are more people than ever before in older age g. Over 11 Mn people – 18.6% of the total population – were aged 65 years or older. Diabetes, heart issues, and high blood pressure are just a few of the additional health issues that senior individuals may have as a result of renal illnesses or disturbances in normal kidney function. Thus, treating renal problems as soon as possible is extremely important. Increasing financing for the development of new, high-tech products as well as an increase in the number of people with end-stage renal illnesses and kidney failure

Market Restraints

The complications during the treatment of dialysis might restrict the overall market growth. Lack of awareness about kidney diseases and product recalls might limit the market growth.

Competitive Landscape

Key Players

DaVita
Baxter
Medtronic
Fresenius Kabi
Physidia
Diaverum
Nxstage Medical Inc.
Merck Kgaa,
Cantel Medical

Notable Recent Deals

June 2022 - Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNFs), announced that Chicago-based RenPro Renal Services, which provides dialysis services to patients in SNFs in Illinois, Indiana, Ohio, and Kentucky, has merged into the company under the Dialyze Direct name

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of UK Dialysis Market Services

National Kidney Federation (NKF) has been addressing the increasing cost of home dialysis as part of our home dialysis campaign. NHS England will be actioning reimbursement of additional utility costs for patients receiving home dialysis and there are systems in place to enable patients to reclaim these costs from their dialysis provider, and looking to include utility cost reimbursement in revised national renal service specifications when they are re-written/reviewed.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Dialysis Market Segmentation

The Dialysis Market is segmented as mentioned below:

By Type (Revenue, USD Billion):

Hemodialysis (HD)
- Conventional Hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
Peritoneal dialysis (PD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)

By Product & Services (Revenue, USD Billion):

Equipment
- Dialysis Machines
- Water Treatment Systems
- Others Dialysis Equipment
Consumables
- Dialyzers
- Catheters
- Other Dialysis Consumables
Dialysis Drugs
Services

By End User (Revenue, USD Billion):

In-center dialysis
Home dialysis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.